波士顿标准2.0版与1.5版预测脑淀粉样血管病相关脑出血复发的比较
研究比较波士顿标准2.0版与1.5版诊断的可能脑淀粉样血管病患者脑出血复发风险,纳入443例脑出血患者,中位随访5.7年。仅符合2.0版非出血性白质特征的患者复发率很低,低于1.5版诊断者(P<0.001),提示可能脑淀粉样血管病的复发风险谱较宽。
要点
- 波士顿标准2.0版新增非出血性白质特征,可能改变脑淀粉样血管病患者的脑出血复发风险分层。
- 仅符合2.0版标准的20例患者复发率很低(0.9/100人年),低于1.5版诊断者(P<0.001)。
- 1.5版诊断的可能脑淀粉样血管病患者脑出血复发率高于2.0版诊断者(10.9 vs 8.5/100人年)。
核心结论
- 研究提示可能脑淀粉样血管病患者的脑出血复发风险谱较宽;仅基于2.0版新增非出血性白质标志物诊断的患者复发风险远低于1.5版诊断者,与不符合任何可能脑淀粉样血管病标准的患者相当。
研究设计与样本
- 连续纳入脑出血且有脑磁共振成像的患者,排除大血管或结构性病因,比较波士顿标准2.0版与1.5版诊断可能脑淀粉样血管病的脑出血复发风险,采用生存分析。
主要发现
- 443例患者中59例(13.3%)出现复发性脑出血,中位随访5.7年(共2682患者年)。
- 2.0版标准诊断的可能脑淀粉样血管病患者中37/102例(36.3%)复发,1.5版标准诊断者中36/82例(43.9%)复发。
- 1.5版诊断的可能脑淀粉样血管病患者脑出血复发率为10.9/100人年(95%CI 7.8-15.1),高于2.0版诊断者的8.5/100人年(95%CI 6.1-11.7)。
- 仅由2.0版标准定义为可能脑淀粉样血管病的20例患者复发率很低(0.9/100人年,95%CI 0.1-6.7),低于1.5版诊断者(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intracerebral hemorrhage (ICH) caused by cerebral amyloid angiopathy (CAA) has a high recurrence risk. The Boston criteria, while not designed to predict recurrence, are commonly used for in vivo diagnosis of CAA and have recently been revised to the version 2.0 (v2.0), introducing nonhemorrhagic white matter features. We investigated whether the new v2.0 criteria change ICH recurrence risk in patients with probable CAA. METHODS: We assessed ICH recurrence risk in consecutive patients with ICH and available brain magnetic resonance imaging. Patients with macrovascular or structural causes were excluded. Recurrent ICH was determined using electronic health records and confirmed by neuroimaging. We compared ICH recurrence risk for Boston criteria v2.0 versus v1.5 for probable CAA using survival analysis. RESULTS: Fifty-nine of 443 patients (13.3%) had recurrent ICH over a median follow-up of 5.7 years (2682 patient-years). Thirty-seven out of one hundred two patients (36.3%) with probable CAA according to the Boston criteria v2.0 had recurrent ICH compared with 36/82 patients (43.9%) according to the v1.5 criteria. Patients with probable CAA according to the Boston v1.5 criteria had a higher ICH recurrence rate (10.9 per 100 person-years [95% CI, 7.8-15.1]) compared with those diagnosed by the v2.0 criteria (8.5 per 100 person-years [95% CI, 6.1-11.7]). The 20 patients defined as probable CAA only by the v2.0 criteria had a very low recurrence rate (0.9 per 100 person-years [95% CI, 0.1-6.7]), lower than those diagnosed using the v1.5 criteria (P<0.001). CONCLUSIONS: Our findings suggest a wide spectrum of ICH recurrence risk in patients with probable CAA. Patients with ICH diagnosed with CAA based only on the nonhemorrhagic white matter markers introduced in the Boston v2.0 criteria had a much lower risk of recurrence than those diagnosed with the previous Boston criteria v1.5, comparable to that of patients with ICH not fulfilling any probable CAA criteria.
引用
- Fandler-Höfler S, Gattringer T, Enzinger C, et al. Comparison of Boston Criteria v2.0/v1.5 for Cerebral Amyloid Angiopathy to Predict Recurrent Intracerebral Hemorrhage. Stroke. 2023. PMID: 37264913. doi:10.1161/STROKEAHA.122.042407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。